Skip to content
healthcare.dev
Get a free key

JYLAMVO

NDC 81927-204, Methotrexate, solution, from SHORLA ONCOLOGY INC..

Product NDC
81927-204
Status
Listed
Labeler
SHORLA ONCOLOGY INC.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212479
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81927-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE2 mg/mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
81927-204-01819270204011 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/96e931f5-51ae-4bdf-a441-bb0dd26d4c0e

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=81927-204

Use it

Look up 81927-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81927-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81927-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.